(ETAR) on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis (SSc) patients. PubMed, Arthritis Res Ther, 2014 Mar 11;16(2):R65. (Also see: Antibodies in Systemic Scleroderma and Causes of Scleroderma: Endothelin)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.